ArticleCancers2025

Ibrutinib in Combination with Lenalidomide Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma (AFT-15).

Yvonne Efebera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.